Dear Healthcare Professional, Shortage of AUGMENTIN DUO FORTE tablet blister pack 875mg/125mg (Amoxicillin Trihydrate and Potassium Clavulanate) alternative supply arrangement Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered AUGMENTIN DUO FORTE tablet blister pack 875mg/125mg (Amoxicillin Trihydrate and Potassium Clavulanate) AUST R: 54900 sponsored by Aspen Pharmacare Australia is currently in shortage due to an unexpected increase in

Dear Healthcare Professional, Shortage of AUGMENTIN DUO FORTE tablet blister pack 875mg/125mg (Amoxicillin Trihydrate and Potassium Clavulanate) alternative supply arrangement Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered AUGMENTIN DUO FORTE tablet blister pack 875mg/125mg (Amoxicillin Trihydrate and Potassium Clavulanate) AUST R: 54900 sponsored by Aspen Pharmacare Australia is currently in shortage due to an unexpected increase in

Dear Healthcare Professional, METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe AUST R: 75013 - shortage and alternative supply arrangement Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe AUST R: 75013. ProPG has arranged for an alternative product TNKASE tenecteplase 50mg powder for solution kit (Canada). The S19A product

Dear Healthcare Professional, METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe AUST R: 75013 - shortage and alternative supply arrangement Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe AUST R: 75013. ProPG has arranged for an alternative product TNKASE tenecteplase 50mg powder for solution kit (USA). The S19A product is

Dear Healthcare Professional, OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen AUST R: 308324 - shortage and alternative supply arrangement Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen AUST R: 308324. ProPG has arranged for an alternative product Ozempic 0.25mg & 0.5mg solution for injection in pre-filled pen

Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered DITROPAN oxybutynin hydrochloride 5mg tablet bottle AUST R: 48965. ProPG has arranged for an alternative product Oxybutynin Chloride Tablets, USP 5mg (Novitium Pharma, USA) . The S19A product is registered and marketed in the USA and the supply is authorized under an exemption granted by the TGA under Section 19A of the Therapeutic Goods Act, 1989 until 31 January 2023.

Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered BENPEN benzylpenicillin (as sodium) 3g and 1.2g powder for injection vial, AUST R: 10326 ProPG has arranged for an alternative product Benzylpenicillin sodium 1200 mg powder for injection (Genus Pharmaceuticals).

​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th September 2022. Import and supply approved until: 30th Sept 2022 ​ Imipramine 25mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 25mg not available. ​ Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 25 MG 100 TABLETS (LEADING PHARMA LLC) S19a​ Stock availability: On hand Ordering Orders can be placed directly via our website

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered products on a temporary basis: XYLOCAINE 2% with ADRENALINE 1-200000 VIAL pack of 10x20ml (ASPEN Canada) This products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st July 2022. Please contact us for more information. Link to Dear Health Care P

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered Gemfibrozil products on a temporary basis: Gemfibrozil Tablets USP 600mg (Cipla USA) This products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st July 2022. Please contact us for more information. Link to Dear Health Care Professional Label